Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 42.

Murphy, Alexander D, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, White, Ann, Irving, Alys, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Ray, Ruby, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Mahmood, Reem D., Karanth, Suman, Zhou, Cong, Pugh, Julia, Wheeler, Chelsey, Roberts, Victoria, Arnetoli, Giorgio, Salih, Zena, Hasan, Jurjees, Mitchell, Claire, Morgan, Robert D., Clamp, Andrew R. and Jayson, Gordon C. 2024. Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial. International Journal of Gynecological Cancer 34 , pp. 1034-1040. 10.1136/ijgc-2024-005455
file

Randell, Elizabeth ORCID: https://orcid.org/0000-0002-1606-3175, Nollett, Claire ORCID: https://orcid.org/0000-0001-6676-4933, Henley, Josie, Smallman, Kim ORCID: https://orcid.org/0000-0002-9283-8120, Johnson, Sean, Meister, Lena, McNamara, Rachel ORCID: https://orcid.org/0000-0002-7280-1611, Wilkins, David ORCID: https://orcid.org/0000-0003-2780-0385, Segrott, Jeremy ORCID: https://orcid.org/0000-0001-6215-0870, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Wakelyn, Jenifer, McKay, Kathy, Bordea, Ekaterina, Totsika, Vaso and Kennedy, Eilis 2024. Watch Me Play!: protocol for a feasibility study of a remotely delivered intervention to promote mental health resilience for children (ages 0–8) across UK early years and children’s services. Pilot and Feasibility Studies 10 (1) , 55. 10.1186/s40814-024-01491-7
file

Jones, Sadie Esme Fleur, Hudson, Emma, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Murphy, Jamie, Peters, Christopher, Gwynne, Sarah, Frost, Jonathan, Brogden, Elena, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970 and Hamilton, Rebecca 2023. Launching the PICCOS trial: PIPAC in cancers of the colon, ovary and stomach. Presented at: European Society of Gynaecological Society Congress, Istanbul, Turkey, 28 September - 01 October 2023. International Journal of Gynecological Cancer. BMJ Publishing Group, 10.1136/ijgc-2023-ESGO.690

Beresford, Mark, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia ORCID: https://orcid.org/0000-0001-6483-2015, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496 2023. Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial. BJC Reports 1 (1) , 13. 10.1038/s44276-023-00016-8
filefile

Kitson, Terri ORCID: https://orcid.org/0000-0001-6333-046X, Osborne, Emma, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Pease, Nikki, Alikhan, Raza, Bryant, Catherine, Groves, Tristan, Wallace, Rebecca, Walker, Sarah, Seddon, Kathy, Smith, Deb, Raisanen, Lawrence, Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Thomas, Ian, Upton, Laura and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052 2023. HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative care. BMJ Open 13 (9) , e073049. 10.1136/bmjopen-2023-073049
file

Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, White, Ann, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052 2022. Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial. EClinicalMedicine 52 , 101595. 10.1016/j.eclinm.2022.101595
file

Howell, Sacha J., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Ingarfield, Kate, Butler, Rachel, Morgan, Sian, Meissner, Magdalena, Bale, Catherine, Bezecny, Pavel, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, De Bruin, Elza C., Schiavon, Gaia, Foxley, Andrew and Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496 2022. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. The Lancet Oncology 23 (7) , pp. 851-864. 10.1016/s1470-2045(22)00284-4
file

Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Taylor, Paul, Sheaff, Michael, Rudd, Robin M., Gaba, Aarti, Busacca, Sara, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, Darlison, Liz, Poile, Charlotte, Richards, Cathy, Jordan, Peter-Wells, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052 2022. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. eClinicalMedicine 48 , 101432. 10.1016/j.eclinm.2022.101432
file

Jones, Rob, Crabb, Simon, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, Tony, Huddart, Robert, Birtle, Alison, Evans, Linda, Lester, Jason, Jagdev, Satinder, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Huang, Chao, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth 2020. A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin. BJU International 126 (2) , pp. 292-299. 10.1111/bju.15096
file

Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J. 2020. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. Lancet Oncology 21 (3) , pp. 345-347. 10.1016/S1470-2045(19)30817-4
file

Lester, Jason F, Casbard, Angela C ORCID: https://orcid.org/0000-0001-6241-3052, Al-Taei, Saly, Harrop, Richard, Katona, Lajos ORCID: https://orcid.org/0000-0001-9929-0543, Attanoos, Richard L, Tabi, Zsuzsanna and Griffiths, Gareth O 2018. A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial. OncoImmunology 7 (12) , e1457597. 10.1080/2162402X.2018.1457597
file

Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Farewell, Daniel ORCID: https://orcid.org/0000-0002-8871-1653, Barrett-Lee, Peter, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Hawthorne, Anthony Barney, Hurt, Christopher ORCID: https://orcid.org/0000-0003-1206-8355, Murray, Nick, Probert, Chris, Stenson, Rachel and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 2017. The use of randomisation-based efficacy estimators in non-inferiority trials. Trials 18 (1) , 117. 10.1186/s13063-017-1837-3
file

Harrop, Emily ORCID: https://orcid.org/0000-0003-2820-0023, Kelly, John, Griffiths, Gareth, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 2016. Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17 , 35. 10.1186/s13063-016-1173-z
file

Jones, Robert J., Crabb, S. J., Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840, Elliott, T., Huddart, R. A., Birtie, A. J., Evans, L., Lester, Jason Francis, Huang, Chao, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873 and Griffiths, Gareth 2016. TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin [Abstract]. American Journal of Clinical Oncology 34 (S25) , 448.

Gillespie, David ORCID: https://orcid.org/0000-0002-6934-2928, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Farewell, Daniel ORCID: https://orcid.org/0000-0002-8871-1653, Hawthorne, Antony, Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Probert, Chris, Stenson, Rachel, Barrett-Lee, Peter ORCID: https://orcid.org/0000-0002-6246-7357, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murray, Nick 2015. The use of randomisation-based efficacy estimators in non-inferiority trials [Poster Presentation]. Trials 16 (Suppl) , P129. 10.1186/1745-6215-16-S2-P129
file

Noble, Simon I. ORCID: https://orcid.org/0000-0001-5425-2383, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Sivell, Stephanie ORCID: https://orcid.org/0000-0003-0253-1860, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley ORCID: https://orcid.org/0000-0003-0170-7027 and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830
file

Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003
file

Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1

Barrett-Lee, Peter, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Abraham, Jacinta, Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Coleman, Robert, Simmonds, Peter, Timmins, Hayley, Wheatley, Duncan, Grieve, Robert, Griffiths, Gareth and Murray, Nick 2014. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. Lancet Oncology 15 (1) , pp. 114-122. 10.1016/S1470-2045(13)70539-4

Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, David, Fitzmaurice, David A., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 and Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383 2014. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study. Trials 15 (1) , 122. 10.1186/1745-6215-15-122
file

Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Smith, J., Baglin, T., Griffiths, G., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, D., Fitzmaurice, D., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Rose, P., Cohen, A., Johnson, M., Maraveyas, A., Bell, J., Toone, H. and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 2014. Anticoagulation length in cancer associated thrombosis: a mixed-methods feasibility study. Presented at: International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy, 9-11 May 2014.

Harrop, Emily ORCID: https://orcid.org/0000-0003-2820-0023, Kelly, John, Neal, David, Dasgupta, Prokar, Basnett, Gillian, Huddart, Robert, Barham, Allan, Thompson, Colin, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Jundi, Hala, Griffiths, Gareth and Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 2013. ‘Once I knew there was a choice, I wanted to exercise that choice': using qualitative methods to understand why patients decline surgical trials. Trials 14 (S1) , P9 (2013). 10.1186/1745-6215-14-s1-p9
file

Powell, James R., Dojcinov, Stefan, King, Louise, Wosniak, Sue, Gerry, Stephen, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Bailey, Hazel, Gallop-Evans, Eve and Maughan, Tim 2013. Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab. Leukemia & Lymphoma 54 (5) , pp. 959-966. 10.3109/10428194.2012.733875

Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Wills, Lauren, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Crosby, Thomas David Lewis, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Griffiths, G. 2009. Implementation of a QA RT substudy for SCOPE 1; Preliminary results for test cases [Abstract]. Clinical Oncology 21 (3) , p. 255. 10.1016/j.clon.2009.01.001,

Morgan, M. A., Lewis, W. G., Casbard, A. ORCID: https://orcid.org/0000-0001-6241-3052, Roberts, S. A., Adams, R. ORCID: https://orcid.org/0000-0003-3915-7243, Clark, G. W. B., Havard, T. J. and Crosby, T. D. L. 2009. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. British Journal of Surgery 96 (11) , pp. 1300-1307. 10.1002/bjs.6705

Llewelyn, C. A., Wells, A. W., Amin, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Johnson, A. J., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M. 2009. The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies. Transfusion Medicine 19 (2) , pp. 89-98. 10.1111/j.1365-3148.2009.00911.x

Wells, A. W., Llewelyn, C. A., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Johnson, A. J., Amin, M., Ballard, Sian, Buck, J., Malfroy, M., Murphy, M. F. and Williamson, L. M. 2009. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfusion Medicine 19 (6) , pp. 315-328. 10.1111/j.1365-3148.2009.00933.x

Cooke, D., Hurel, S. J., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Steed, L., Walker, S., Meredith, S., Nunn, A. J., Manca, A., Sculpher, M., Barnard, M., Kerr, D., Weaver, J. U., Ahlquist, J. and Newman, S. P. 2009. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1cin insulin-treated diabetes (MITRE Study). Diabetic Medicine 26 (5) , pp. 540-547. 10.1111/j.1464-5491.2009.02723.x

Williamson, Lorna M., Stainsby, Dorothy, Jones, Hilary, Love, Elizabeth, Chapman, Catherine E., Navarrete, Cristina, Lucas, Geoff, Beatty, Cynthia, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Cohen, Hannah 2007. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 47 (8) , pp. 1455-1467. 10.1111/j.1537-2995.2007.01281.x

Ghevaert, Cedric, Campbell, Kate, Stafford, Prachi, Metcalfe, Paul, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Smith, Graham A., Allen, Dave, Ranasinghe, Edmund, Williamson, Lorna M. and Ouwehand, Willem H. 2007. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion 47 (7) , pp. 1296-1305. 10.1111/j.1537-2995.2007.01273.x

Stanworth, S. J., Dyer, C., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murphy, M. F. 2006. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding. Vox Sanguinis 91 (1) , pp. 63-69. 10.1111/j.1423-0410.2006.00785.x

Williamson, M., Stainsby, D., Jones, H., Love, E., Chapman, C., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052 and Cohen, H. 2006. Haemovigilance reports of post-transfusion purpura and transfusion-associated graft-versus-host disease before and after implementation of universal leucocyte depletion in the UK. Vox Sanguinis 91 (Supp 3) , p. 15. 10.1111/j.0042-9007.2006.vox_v91_is3_mondaysessions.x

Davies, Amanda, Staves, Julie, Kay, Jonathan, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Murphy, Michael F. 2006. End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46 (3) , pp. 352-364. 10.1111/j.1537-2995.2006.00729.x

Grover, M., Talwalkar, S., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Boralessa, H., Contreras, M., Boralessa, H., Brett, S., Goldhill, D. R. and Soni, N. 2006. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sanguinis 90 (2) , pp. 105-112. 10.1111/j.1423-0410.2006.00730.x

Buck, Jackie, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Llewelyn, Charlotte, Johnson, Tony, Davies, Sally and Williamson, Lorna 2005. Preoperative transfusion in sickle cell disease: a survey of practice in England. European Journal of Haematology 75 (1) , pp. 14-21. 10.1111/j.1600-0609.2005.00412.x

Segal, H. C., Briggs, C., Kunka, S., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Harrison, P., Machin, S. J. and Murphy, M. F. 2005. Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. British Journal of Haematology 128 (4) , pp. 520-525. 10.1111/j.1365-2141.2004.05352.x

Allain, J.-P., Anokwa, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Owusu-Ofori, S. and Dennis-Antwi, J. 2004. Sociology and behaviour of West African blood donors: the impact of religion on human immunodeficiency virus infection. Vox Sanguinis 87 (4) , pp. 233-240. 10.1111/j.1423-0410.2004.00578.x

McPherson, K., Metcalfe, M.A., Herbert, A., Maresh, M., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Hargreaves, J., Bridgman, S. and Clarke, A. 2004. Severe complications of hysterectomy: the VALUE study. BJOG - an International Journal of Obstetrics and Gynaecology 111 (7) , pp. 688-694. 10.1111/j.1471-0528.2004.00174.x

Boralessa, H., Cockburn, H., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 and Contreras, M. 2004. Review of transfusion practice in orthopaedic surgery. Current Orthopaedics 18 (2) , pp. 126-134. 10.1016/j.cuor.2003.11.001

Strang, J. I. G., Nunn, A. J., Johnson, D. A., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Gibson, D. G. and Girling, D. J. 2004. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM: An International Journal of Medicine 97 (8) , pp. 525-535. 10.1093/qjmed/hch086

Selden, C., Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Themis, M. and Hodgson, H. J. 2003. Characterization of long-term survival of syngeneic hepatocytes in rat peritoneum. Cell Transplantation 12 (6) , pp. 569-578.

Maresh, M. J. A., Metcalfe, M. A., McPherson, Klim, Overton, C., Hall, V., Hargreaves, J., Bridgman, S., Dobbins, J. and Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052 2002. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG: An International Journal of Obstetrics & Gynaecology 109 (3) , pp. 302-312. 10.1016/S1470-0328(02)01282-X

This list was generated on Thu Sep 19 07:44:32 2024 BST.


Maintained by Cardiff University Information Services